Systematic review evaluates handwriting abnormalities for diagnosis and treatment in neurological disorders, suggesting clinical implications.
To characterize disease-specific handwriting abnormalities across neurological disorders involving motor and cognitive impairment and to evaluate handwriting as a scalable, non-invasive biomarker for diagnosis, disease stratification, and treatment monitoring.
No takes yet. Share an insight, caveat, or question.
Paul et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: